AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.

Pharmaceutical

AbbVie

Janet Gottlieb

Vincent Ciro

Carrie Strom is Senior Vice President, [AbbVie](/org/abbvie), and President, Global [Allergan](/org/allergan) Aesthetics and has served in this role since May 2020.
Prior to joining [AbbVie](/org/abbvie), Ms. Strom served as Senior Vice President of U.S. Medical Aesthetics at [Allergan](/org/allergan)® beginning in May 2018, overseeing the aesthetic portfolio for the multi-billion dollar U.S. business.

Previously, Ms. Strom was Vice President of Marketing, Plastic Surgery and Regenerative Medicine at [Allergan](/org/allergan) and she was instrumental in the $2.8B acquisition and integration of LifeCell.

Before [Allergan](/org/allergan), Ms. Strom spent over 10 years at [Pfizer](/org/pfizer) where she led marketing for a leading statin and held various other sales and marketing roles.

Ms. Strom received a B.A. in Communications from the University of Colorado, Boulder. She is an advocate for women in business and sits on the board for the Orange County chapter of the Girls Inc. organization. At [AbbVie](/org/abbvie), she is the executive chair of the PRIDE Employee Resource Group.

Carrie C. Strom

Perry Siatis is Executive Vice President, General Counsel and Secretary, a member of the executive leadership team, and a senior legal advisor and strategist for AbbVie’s global Legal Department. He is credited with negotiating highly successful global business deals, navigating complex government policy, and providing strategic legal guidance for multiple billion-dollar brands. In 2020, he led the legal strategy for the acquisition of Allergan, one of the largest acquisitions in pharmaceutical history.

Mr. Siatis began his career by practicing commercial and intellectual property (IP) litigation at DLA Piper LLP. He joined Abbott in 2005 as Counsel and progressed to Division Counsel, IP Litigation and later became Divisional Vice President and Section Head, IP Strategy. In January 2013, Mr. Siatis joined AbbVie where he served as Vice President, Biologic Strategic Development and Legal Regulatory where he strengthened the legal strategy surrounding AbbVie’s premier biologic and the world’s top selling drug. Prior to his most recent role, Mr. Siatis was the Senior Vice President of Legal Transactions and R&D/Alliance Management and Chief Ethics and Compliance Officer.

Presently, Mr. Siatis is responsible for Legal Transactions, including M&A and licensing, Alliance Management and R&D Legal; Litigation, Legal Compliance and Regulatory; Intellectual Property and Strategy; Corporate Legal, Governance, and Operations; and Global Commercial Legal, including the Legal team for Allergan Aesthetics. He is a champion of diversity and inclusion and has spearheaded AbbVie Legal engagements with Historically Black Colleges and Universities and the National Association of Minority & Women Owned Law Firms.  

Mr. Siatis earned a bachelor's degree in accounting from George Mason University and a Juris Doctorate degree from Brigham Young University.

Perry C. Siatis

Jeffrey R. Stewart is Executive Vice President, Chief Commercial Officer. He is responsible for leading the largest commercial area for the enterprise encompassing multiple therapeutic areas across immunology, oncology, virology, eye care, neuroscience, endo-metabolics, gastroenterology, specialty products and women’s health.

Mr. Stewart joined Abbott in 1992 as part of TAP, Abbott’s former U.S. joint venture with Takeda Chemical Industries. Following his time with TAP, Mr. Stewart held various leadership positions in Abbott’s U.S. and international pharmaceutical businesses, including Divisional Vice President, Immunology; Divisional Vice President, Primary Care; General Manager, Virology; and General Manager, United Kingdom. Prior to [AbbVie](/org/abbvie)'s separation from Abbott in January 2013, Mr. Stewart served as Vice President, Abbott Proprietary Pharmaceutical Division, United States.

Mr. Stewart previously led the U.S. Area for 10 years, including most recently as Senior Vice President, U.S. Commercial Operations.
Mr. Stewart previously served on the Board of the [National Pharmaceutical Council](/org/national-pharmaceutical-council) and serves on the Board of the Pharmaceutical Research and Manufacturers of America (PhRMA). At [AbbVie](/org/abbvie), he is the executive chair of the PRIDE Employee Resource Group.

Jeffrey R. Stewart

Martin Hayes

vishvas garg

Neil Cohen

Carlos Vinhas

Laura Schumacher is Vice Chairman, External Affairs and Chief Legal Officer, a member of the executive leadership team, and responsible for global legal, health economics outcomes research, corporate brand and communications and government affairs.

Prior to [AbbVie](/org/abbvie)’s separation from Abbott, Ms. Schumacher served as Executive Vice President, General Counsel. Both at Abbott and [AbbVie](/org/abbvie), Ms. Schumacher has led Business Development and Ventures & Early Stage Collaborations. Ms. Schumacher joined Abbott as a litigation attorney, held various leadership positions in the company, and was appointed Senior Vice President, General Counsel in 2005. Prior to joining Abbott, Ms. Schumacher was an associate attorney with the law firm Schiff, Hardin & Waite in Chicago, Illinois.

Ms. Schumacher serves on the Board of Directors of General Dynamics Corporation, the Board of Trustees for [Ronald McDonald House Charities](/org/ronald-mcdonald-house-charities) and the Notre Dame Law School Advisory Board. She is also a member of the [National Association of Corporate Directors](/org/national-association-of-corporate-directors), [American Bar Association](/org/american-bar-association) and the Economic Club of Chicago.

She earned a bachelor's degree in business administration from the [University of Notre Dame](/org/university-of-notre-dame) and a juris doctorate from the University of Wisconsin at Madison, U.S.A.

Laura J. Schumacher

Tim Richmond is Executive Vice President, Chief Human Resources Officer for [AbbVie](/org/abbvie), responsible for leading the global human resources function focused on engaging high-performing employees and amplifying a culture that drives business performance. As a result of this focus, [AbbVie](/org/abbvie) has been named to more than 40 Great Place to Work® and Top Employer® lists and is prominently recognized on “Best of” lists related to diversity, leadership and engagement, as well as for corporate responsibility and business performance.

Prior to [AbbVie](/org/abbvie)’s separation from Abbott, Mr. Richmond served as Divisional Vice President, Compensation and Benefits. Previously, he held various human resources management positions at Abbott Laboratories and 3M Company. 

Mr. Richmond serves on the Board of Directors for the Warriors and Quiet Waters Foundation and the Travis Manion Foundation, both focused on supporting veterans and strengthening communities. At [AbbVie](/org/abbvie), he is the executive chair of the Veterans Employee Resource Group.

Timothy J. Richmond

Rae Livingston serves as [AbbVie](/org/abbvie)’s Chief Equality Officer. In this role, she leads company-wide efforts to address the issues of race, equality and diversity – both inside and outside of [AbbVie](/org/abbvie). She previously served as Vice President, Business Human Resources, Corporate Functions and U.S. Employee Relations since she joined [AbbVie](/org/abbvie) in 2016.

Prior to joining [AbbVie](/org/abbvie), Ms. Livingston held several positions of increasing global responsibility with [Rockwell Automation](/org/rockwell-automation), where she most recently served as the vice president of human resources for headquarters functions, culture of inclusion and mergers and acquisitions. She also gained key experience in business human resources and mergers & acquisitions with Medtronic, Inc. and JP Morgan Chase.

Ms. Livingston has served as board chair for the YWCA of Southeast Wisconsin and as a member of the executive committee. 

She earned her bachelor’s and master’s degrees in business administration from [Florida Agricultural and Mechanical University](/org/florida-agricultural-and-mechanical-university) and is a certified senior professional in human resources (SPHR). 

Rae L. Livingston

Rob Michael is Vice Chairman and President. A member of [AbbVie](/org/abbvie)’s Executive Leadership Team, Mr. Michael is responsible for global commercial and financial operations of the company. Previously, he served as Vice Chairman, Finance and Commercial Operations and Chief Financial Officer.

Mr. Michael has nearly 30 years of experience including leadership roles across multiple businesses, including pharmaceuticals, aesthetics, diagnostics, diabetes care and nutrition. He began his career with Abbott as a member of the Financial Development Program and ultimately served as Division Controller, Nutrition Supply Chain and Division Controller, Molecular Diagnostics, among other roles.

Upon [AbbVie](/org/abbvie)’s separation from Abbott in 2013, Mr. Michael established and led the company’s first financial planning organization as Vice President, [AbbVie](/org/abbvie) Financial Planning and Analysis. He then held a series of leadership roles of increasing responsibility including Vice President, Controller for Commercial Operations; Vice President, Treasurer; and Vice President, Corporate Controller. He was appointed Chief Financial Officer in 2018 and Vice Chairman, Finance and Commercial Operations in 2021.

Mr. Michael earned a bachelor’s degree in accounting from Indiana University Kelley School of Business and a Master of Business Administration from University of California Los Angeles Anderson School of Management.

Robert A. Michael

Scott Reents was named Senior Vice President and Chief Financial Officer in June 2022. Prior to this, Scott was Vice President of Tax and Treasury. Scott joined the company in 2013.

Scott Reents

Henry Gosebruch is Executive Vice President, Chief Strategy Officer at [AbbVie](/org/abbvie), responsible for corporate strategy, business development and acquisitions, search and evaluation, alliance management and [AbbVie](/org/abbvie) Ventures.

Since joining [AbbVie](/org/abbvie) in December 2015, Mr. Gosebruch and his team have completed more than 75 partnering, collaboration, mergers & acquisitions (M&A) and venture transactions to bolster [AbbVie](/org/abbvie)’s commercial franchises and pipeline of innovative preclinical and clinical development programs, working closely with [AbbVie](/org/abbvie) colleagues globally. 

Prior to joining [AbbVie](/org/abbvie), Mr. Gosebruch was Co-Head of J.P. Morgan’s North American M&A Group based in New York. He worked on numerous complex M&A transactions involving companies in more than 20 countries.

Mr. Gosebruch serves on the board of [Aptinyx](/org/aptinyx). He is also member of the Advisory Board for the Life Sciences & Management Program at the [University of Pennsylvania](/org/university-of-pennsylvania). At [AbbVie](/org/abbvie), he is the executive chair of the Asian Leadership Network Employee Resource Group.

Henry O. Gosebruch

Dr. Azita Saleki-Gerhardt is Executive Vice President, Operations, leading a team of scientific, engineering, business, quality, supply chain, security, purchasing and manufacturing professionals responsible for supply and distribution of all [AbbVie](/org/abbvie) products, as well as a number of corporate services.

Dr. Saleki-Gerhardt joined Abbott in 1993 as a research scientist. She has worked in key leadership positions of increasing responsibility across a broad range of areas, including science and technology, manufacturing and quality assurance. Following [AbbVie](/org/abbvie)’s separation from Abbott, Dr. Saleki-Gerhardt was appointed head of [AbbVie](/org/abbvie) Operations.    

She has been published in a number of scientific publications and has been awarded several patents related to pharmaceutical sciences.

Dr. Saleki-Gerhardt is a member of the Board of Directors for [Entegris](/org/entegris). She is a member of the Dean’s Advisory Boards for the School of International Studies and School of Pharmacy at UW-Madison. At [AbbVie](/org/abbvie), she is the executive chair of the Women Leaders in Action Employee Resource Group.

Dr. Saleki-Gerhardt earned her bachelor’s, master’s and doctorate degrees in pharmaceutics from the University of Wisconsin at Madison, U.S.A.

Azita Saleki-Gerhardt

Before joining [AbbVie](/org/abbvie), Mike spent 24 years at Abbott in a range of roles within logistics. He holds a BBA from Wisconsin-Whitewater and an MBA from Lake Forrest.

AbbVie

Org chart

Teams

Board of Directors

Leadership Team

CEO and Executive Team

Discover similar companies